CONTENTS

Issue 71 | June 2018

BIOTECH M&A: THE 2018 SURGE

Analysts are predicting a surge of M&A activity in the biotechnology space

the manufacturing capacity crunch

Can the gene and cell therapy revolution be successfully scaled up?

HOW DRUGS AFFECT THE MICROBIOME

One in four non-antibiotic drugs affect the growth of gut bacteria

TRACING THE STORY OF MUMPS

A history of mumps and the drugs used to treat the disease

INSIDE SWISS PHARMA

Why is Switzerland so conducive to pharmaceutical success?

DOES NICE NEED AN OVERHAUL?

Is the UK medical board responsible for approving new drugs outdated?

SAVING BILLIONS WITH DIGITAL TECH

UK pharma could save billions through investing in digital tech

Transforming healthcare with digital tech

The industry is undergoing dramatic change as new tech brings disruption

CRISPR: A SEISMIC SHIFT

Gene editing tool CRISPR/Cas9 has electrified the biotech industry

06/06/2019 14:21:35
  • Home | Invest in Tech
  • In this issue
  • Gerteis Company Insight
  • Gerteis
  • Contents
  • DJA
  • News
  • Medelpharm
  • Biotech M&A: will the 2018 surge last?
  • NSF
  • Can the gene and cell therapy revolution scale up?
  • Haselmeier GmbH Company Insight
  • Haselmeier GmbH
  • Gut instinct: how common drugs affect the microbiome
  • HOF Sonderanlagenbau Company Insight
  • HOF Sonderanlagenbau
  • Tracing the story of mumps: a timeline
  • Molnar Company Insight
  • Molnar
  • Inside Swiss pharma: the ideal environment for success
  • Is the UK’s drug evaluation system in need of an overhaul?
  • Scandinavian Health Ltd. Company Insight
  • Scandinavian Health Ltd.
  • Moehs
  • Could digital tech unlock billions in savings for pharma companies?
  • Ecocool
  • CRISPR: a seismic shift in gene editing
  • Mestra AG (Endress + Hauser)
  • Events
  • Pfanstiehl Inc Company Insight
  • Pfanstiehl Inc.
  • Next issue
  • Niconex Medical Ltd
  • Alpex Pharma SA
  • Pall Biotech Company Insight
  • Pall Biotech
  • AtoZ-CRO GmbH
  • WIKA - Disaster prevention
  • Bea Technologies
  • Baxter
  • Suez
  • Raland Compliance Partners